Proteome Science

Table 2 Characteristics of patients with TAA and AAA, and control patients with IA in the validation study

From: Serum proteomic identification and validation of two novel atherosclerotic aortic aneurysm biomarkers, profilin 1 and complement factor D

Parameter	TAA		AAA		control IA
Parameter	n	mean ± SEM	n	mean ± SEM	n	mean ± SEM
Age (yo)	24	67.6 ± 2.3*	39	71.1 ± 1.1*	21	47.1 ± 1.9
Sex, male (n)	16	-	33	-	19	-
Sex, female (n)	8	-	6	-	2	-
Aortic diameter (mm)	22^a	49.0 ± 1.3	34^†	44.6 ± 1.3	-	-
BMI (kg/m²)	24	24.0 ± 0.5*	39	23.8 ± 0.5*	21	21.5 ± 0.7
Total cholesterol (mg/dL)	23^a	180 ± 6	38^†	187 ± 5	20^†	194 ± 7
LDL-C (mg/dL)	22^a	99 ± 6	37^†	106 ± 5	19^†	107 ± 5
HDL-C (mg/dL)	22^a	52 ± 3*	38^†	49 ± 2*	20^†	66 ± 3
Triglycerides (mg/dL)	22^a	142 ± 13*	37^†	181 ± 20*	20^†	90 ± 8
Uric acid (mg/dL)	23^a	5.5 ± 0.3	38^†	5.9 ± 0.2*	20^†	5.0 ± 0.3
CRP (mg/dL)	24	0.21 ± 0.13	37^†	0.17 ± 0.03	19^†	0.13 ± 0.07

LDL-C low-density lipoprotein cholesterol, yo years old
Data are presented as mean ± SEM. *p < 0.05 when compared with control patients with IA
^aThe indicated number was less than the summation of the number of male and female patients in the TAA, AAA, and control IA groups owing to the unavailability of NCVC Biobank clinical data

Back to article page

ISSN: 1477-5956

Contact us

General enquiries: journalsubmissions@springernature.com